Your session is about to expire
← Back to Search
Atomoxetine + Oxybutynin for Sleep Apnea
Study Summary
This trial finds that people with sleep apnea who have certain pathophysiological traits respond better to Atomoxetine-plus-oxybutynin therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 4 trial • 57 Patients • NCT00224016Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a sleep disorder like restless legs, sleep attacks, or unusual behaviors during sleep.I don't have allergies to atomoxetine or oxybutynin, heart, kidney, liver issues, or certain mental health conditions.I am not taking medications that affect my breathing.I am currently taking SNRIs/SSRIs or anticholinergic medications.I do not have any uncontrolled medical conditions.I do not have major neurological disorders, heart failure, or other unstable conditions.I have recent results from a sleep study done under sedation.I have a lung condition that is not sleep-related and causes low oxygen levels.I am currently taking sleep medications.I am currently taking the medication being studied.Developing high blood pressure on the last day of my study medication won't stop my participation.I have or might have sleep apnea.
- Group 1: AtoOxy Predicted Responders
- Group 2: AtoOxy Predicted Nonresponders
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How can I get involved in this experiment?
"The requirements for this study are that the patient must be experiencing obstructive sleep apnea and be between 21 and 70 years old. In total, the researchers need 22 participants."
Are octogenarians excluded from participating in this research?
"This particular study is only recruiting patients that are aged 21-70, while there are other 51 trials for minors and 252 trials targeting an elderly demographic."
Are there any more slots open for this clinical trial?
"Data from clinicaltrials.gov indicates that this particular study is not currently recruiting patients for participation. Although the trial's original posting was on October 1st 2023, the most recent update to the listing was on September 19th 2022. There are however, 311 other trials actively seeking participants."
Share this study with friends
Copy Link
Messenger